- Home
- GRDN vs SRPT Comparison
GRDN vs SRPT Comparison
Compare GRDN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- SRPT
- Stock Information
- Founded
- GRDN 2004
- SRPT 1980
- Country
- GRDN United States
- SRPT United States
- Employees
- GRDN N/A
- SRPT N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- GRDN Consumer Staples
- SRPT Health Care
- Exchange
- GRDN Nasdaq
- SRPT Nasdaq
- Market Cap
- GRDN 1.8B
- SRPT 2.0B
- IPO Year
- GRDN 2024
- SRPT 1997
- Fundamental
- Price
- GRDN $27.24
- SRPT $18.10
- Analyst Decision
- GRDN Strong Buy
- SRPT Hold
- Analyst Count
- GRDN 2
- SRPT 31
- Target Price
- GRDN $24.50
- SRPT $40.61
- AVG Volume (30 Days)
- GRDN 345.7K
- SRPT 7.8M
- Earning Date
- GRDN 11-11-2025
- SRPT 11-05-2025
- Dividend Yield
- GRDN N/A
- SRPT N/A
- EPS Growth
- GRDN N/A
- SRPT N/A
- EPS
- GRDN N/A
- SRPT N/A
- Revenue
- GRDN $1,326,604,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- GRDN $16.17
- SRPT $10.78
- Revenue Next Year
- GRDN $2.31
- SRPT N/A
- P/E Ratio
- GRDN N/A
- SRPT N/A
- Revenue Growth
- GRDN 18.53
- SRPT 64.89
- 52 Week Low
- GRDN $14.16
- SRPT $10.42
- 52 Week High
- GRDN $30.39
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- GRDN 54.36
- SRPT 51.18
- Support Level
- GRDN $27.35
- SRPT N/A
- Resistance Level
- GRDN $30.39
- SRPT $18.21
- Average True Range (ATR)
- GRDN 1.16
- SRPT 0.88
- MACD
- GRDN -0.09
- SRPT -0.71
- Stochastic Oscillator
- GRDN 40.47
- SRPT 92.30
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.